长春中医药大学学报2018，Vol.34Issue(2)：378-380,3.DOI:10.13463/j.cnki.cczyy.2018.02.057
吉非替尼联用中药复方治疗非小细胞肺癌的研究
Research of Gefitinib in the treatment of non-small cell lung cancer with traditional Chinese medicine
摘要
Abstract
Gefitinib, a epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), has achieved good results in the treatment of advanced non-small cell lung cancer (NSCLC). However, the adverse reactions and drug resistance after treatment have seriously hindered. The combination of Gefi tinib and traditional Chinese medicine has significant effect on reducing toxicity and increasing efficiency. It has become a hot research topic at present.关键词
吉非替尼/中药复方/非小细胞肺癌/表皮生长因子受体酪氨酸激酶抑制剂Key words
Gefi tinib/Chinese medicine compound/non-small cell lung cancer/EGFR-TKI分类
医药卫生引用本文复制引用
李楠,李剑男..吉非替尼联用中药复方治疗非小细胞肺癌的研究[J].长春中医药大学学报,2018,34(2):378-380,3.基金项目
吉林省科技厅项目(20170204028YY). （20170204028YY）
